These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8958959)

  • 1. The application of IL-12 to cytokine therapy and gene therapy for tumors.
    Nishimura T; Watanabe K; Yahata T; Uede T; Saiki I; Herrmann SH; Kobayashi M; Habu S
    Ann N Y Acad Sci; 1996 Oct; 795():375-8. PubMed ID: 8958959
    [No Abstract]   [Full Text] [Related]  

  • 2. IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice.
    Harada N; Shimada M; Okano S; Suehiro T; Soejima Y; Tomita Y; Maehara Y
    J Immunol; 2004 Dec; 173(11):6635-44. PubMed ID: 15557154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein.
    Shi Y; Parhar RS; Zou M; Baitei E; Kessie G; Farid NR; Alzahrani A; Al-Mohanna FA
    Hum Gene Ther; 2003 Dec; 14(18):1741-51. PubMed ID: 14670125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
    Brunda MJ; Luistro L; Warrier RR; Wright RB; Hubbard BR; Murphy M; Wolf SF; Gately MK
    J Exp Med; 1993 Oct; 178(4):1223-30. PubMed ID: 8104230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
    Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
    Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiated antitumor effects of interleukin 12 and interferon alpha against B16F10 melanoma in mice.
    Dabrowska A; Giermasz A; Gołab J; Jakóbisiak M
    Neoplasma; 2001; 48(5):358-61. PubMed ID: 11845979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV2-mediated interleukin-12 in the treatment of malignant brain tumors through activation of NK cells.
    Chiu TL; Lin SZ; Hsieh WH; Peng CW
    Int J Oncol; 2009 Dec; 35(6):1361-7. PubMed ID: 19885559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line.
    Korbelik M; Sun J
    Int J Cancer; 2001 Jul; 93(2):269-74. PubMed ID: 11410876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.
    Smyth MJ; Teng MW; Swann J; Kyparissoudis K; Godfrey DI; Hayakawa Y
    J Immunol; 2006 Feb; 176(3):1582-7. PubMed ID: 16424187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of Natural Killer Cell Antimetastatic Activity by IL12 and Checkpoint Blockade.
    Ohs I; Ducimetière L; Marinho J; Kulig P; Becher B; Tugues S
    Cancer Res; 2017 Dec; 77(24):7059-7071. PubMed ID: 29042417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000.
    Nakagawa R; Motoki K; Ueno H; Iijima R; Nakamura H; Kobayashi E; Shimosaka A; Koezuka Y
    Cancer Res; 1998 Mar; 58(6):1202-7. PubMed ID: 9515806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene-modified dendritic cell vaccines.
    Ribas A; Amarnani SN; Buga GM; Butterfield LH; Dissette VB; McBride WH; Glaspy JA; Ignarro LJ; Economou JS
    Cancer Gene Ther; 2002 Nov; 9(11):875-83. PubMed ID: 12386826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
    Martinotti A; Stoppacciaro A; Vagliani M; Melani C; Spreafico F; Wysocka M; Parmiani G; Trinchieri G; Colombo MP
    Eur J Immunol; 1995 Jan; 25(1):137-46. PubMed ID: 7843224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effects of interleukin-12 in pre-clinical and early clinical studies (Review).
    Golab J; Zagozdzon R
    Int J Mol Med; 1999 May; 3(5):537-44. PubMed ID: 10202188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An IL-12/Shh-C domain fusion protein-based IL-12 autocrine loop for sustained natural killer cell activation.
    Zhu L; Zhao Z; Wei Y; Marcotte W; Wagner TE; Yu X
    Int J Oncol; 2012 Aug; 41(2):661-9. PubMed ID: 22581115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent.
    Smyth MJ; Taniguchi M; Street SE
    J Immunol; 2000 Sep; 165(5):2665-70. PubMed ID: 10946296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.
    Ettinghausen SE; Rosenberg SA
    Springer Semin Immunopathol; 1986; 9(1):51-71. PubMed ID: 3523804
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer.
    Tahara H; Lotze MT
    Gene Ther; 1995 Mar; 2(2):96-106. PubMed ID: 7719935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model.
    Hong X; Miller C; Savant-Bhonsale S; Kalkanis SN
    Neurosurgery; 2009 Jun; 64(6):1139-46; discussion 1146-7. PubMed ID: 19487894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.